Thousands of people with the terminal lung-scarring disease pulmonary fibrosis are diagnosed late, reducing their life-expectancy, adversely affecting their quality of life and increasing their chances of hospitalisation.
More from us
Did you know with an ad-lite subscription to Northamptonshire Telegraph, you get 70% fewer ads while viewing the news that matters to you.